Toujeo (insulin glargine injection)

pCPA File Number: 21049
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 1 & 2
Sponsor/Manufacturer:
Sanofi-Aventis Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: